Skip to content

Bodenmaiser Long/Post-Covid Rehabilitation Study

Bodenmaiser Long/Post-Covid Rehabilitation Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032204
Enrollment
200
Registered
2023-11-14
Start date
2023-11-06
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: Participants: Approximately 200 patients with a diagnosis of long/post-Covid who have been treated at the Silberbergklinik since 2021 will be contacted with questionnaires. The following dat

Sponsors

Deutscher Heilstollenverband
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: all nationalities

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

MeasureTime frame
Effectiveness of the overall therapy based on the patient's record and physical parameters (lung function, oxygen saturation): - Doctors' assessment (final report in the patient's file) - Assessment of patients (final report in the patient's file) - Comparison of physical parameters at the beginning and at the end (final results are only partially available) Assessment of the modules by means of a questionnaire: - How do patients rate the treatment modules? • Rating between 1 and 5 • Which modules were particularly appreciated – justification - What improvements did the patients notice as a result of the cure: • Tick items with a rating between 1 and 5 • Were there any modules that had a detrimental effect? • Symptom-related questions (resilience, sleep problems, cough, tiredness, general condition)

Secondary

MeasureTime frame
Estimation of the rate of side effects based on the patient's file: - How many patients have undergone speleotherapy? - What was the frequency of use in a patient? - Were there any discontinuations of the healing gallery therapy - why? o Were there interruptions in other modules – why? - Have significant side effects been observed (and documented)

Countries

Germany

Contacts

Public ContactJoachim Schwarz

Deutscher Heilstollenverband

joachimdschwarz@gmail.com+49 172 3581256

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026